Nanogenix
PrivateLast Round
Grant
Mar 10, 2025
Total Funding Raised
$20,000
Company Overview
Nanogenix operates in Healthcare & Life Sciences and is based in Toronto. Its latest recorded funding round was a Grant round in March 2025.
Nanogenix is a biotechnology company that develops photo-immune cancer therapy platforms using lipid-based nanoparticles.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanogenix Comparables
Compare Nanogenix with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Asper Biogene | 78% | |
| Tempus | 73% | |
| Roche Holding | 73% |
For institutional investors. Book with your work email.
Nanogenix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 10, 2025 | ||||
| Series A | Jul 12, 2023 | ||||
| Grant | Jul 1, 2023 |
For institutional investors. Book with your work email.
Nanogenix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Economic Development Agency for Southern Ontario | Grant |
| Terry Fox Research Institute | Grant |
| NanoMedicines Innovation Network | Grant |
| TIAP | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 10, 2025
$20K grant received from Desjardins Group.
- Jul 12, 2023
Completed a Series A funding round.
For institutional investors. Book with your work email.
Nanogenix Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Nanogenix's valuation, stock price, and market status.
Is Nanogenix a public or private company?
Nanogenix is a private company.
What is the current stock price of Nanogenix?
Nanogenix is a private company, so its shares have no public market price. Caplight tracks Nanogenix's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanogenix worth (valuation)?
Valuation information for Nanogenix is not publicly available.
Can I buy Nanogenix stock?
Nanogenix shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanogenix's last funding round?
Nanogenix's most recent funding round was Grant on March 10, 2025.
Who are the main investors in Nanogenix?
Key investors in Nanogenix include Federal Economic Development Agency for Southern Ontario, Terry Fox Research Institute, NanoMedicines Innovation Network, TIAP.
Will Nanogenix IPO soon?
No public IPO plans have been announced for Nanogenix.
How can I track Nanogenix secondary market activity?
Caplight tracks bids, offers, and trades in Nanogenix's shares on secondary markets.